150 related articles for article (PubMed ID: 28518017)
1. Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin.
Bukreyeva I; Angoulvant A; Bendib I; Gagnard JC; Bourhis JH; Dargère S; Bonhomme J; Thellier M; Gachot B; Wyplosz B
Emerg Infect Dis; 2017 Jun; 23(6):1039-1041. PubMed ID: 28518017
[TBL] [Abstract][Full Text] [Related]
2. Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis.
Audemard A; Le Bellec ML; Carluer L; Dargère S; Verdon R; Castrale C; Lobbedez T; Hurault de Ligny B
Transpl Infect Dis; 2012 Dec; 14(6):E147-9. PubMed ID: 23025483
[TBL] [Abstract][Full Text] [Related]
3. Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review.
Lanternier F; Boutboul D; Menotti J; Chandesris MO; Sarfati C; Mamzer Bruneel MF; Calmus Y; Mechaï F; Viard JP; Lecuit M; Bougnoux ME; Lortholary O
Transpl Infect Dis; 2009 Feb; 11(1):83-8. PubMed ID: 18803616
[TBL] [Abstract][Full Text] [Related]
4. Fumagillin treatment of intestinal microsporidiosis.
Molina JM; Tourneur M; Sarfati C; Chevret S; de Gouvello A; Gobert JG; Balkan S; Derouin F;
N Engl J Med; 2002 Jun; 346(25):1963-9. PubMed ID: 12075057
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microsporidiosis due to Enterocytozoon bieneusi in a pediatric kidney transplant recipient successfully treated with fumagillin.
Godron A; Accoceberry I; Couret A; Llanas B; Harambat J
Transplantation; 2013 Oct; 96(8):e66-7. PubMed ID: 24132119
[No Abstract] [Full Text] [Related]
6. Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant.
Desoubeaux G; Maakaroun-Vermesse Z; Lier C; Bailly E; Morio F; Labarthe F; Bernard L; Chandenier J
Transpl Infect Dis; 2013 Dec; 15(6):E250-9. PubMed ID: 24298986
[TBL] [Abstract][Full Text] [Related]
7. Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.
Molina JM; Goguel J; Sarfati C; Chastang C; Desportes-Livage I; Michiels JF; Maslo C; Katlama C; Cotte L; Leport C; Raffi F; Derouin F; Modaï J
AIDS; 1997 Nov; 11(13):1603-10. PubMed ID: 9365765
[TBL] [Abstract][Full Text] [Related]
8. Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA.
Molina JM; Goguel J; Sarfati C; Michiels JF; Desportes-Livage I; Balkan S; Chastang C; Cotte L; Maslo C; Struxiano A; Derouin F; Decazes JM
AIDS; 2000 Jul; 14(10):1341-8. PubMed ID: 10930148
[TBL] [Abstract][Full Text] [Related]
9. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients.
Champion L; Durrbach A; Lang P; Delahousse M; Chauvet C; Sarfati C; Glotz D; Molina JM
Am J Transplant; 2010 Aug; 10(8):1925-30. PubMed ID: 20636462
[TBL] [Abstract][Full Text] [Related]
10. Development of a real-time polymerase-chain-reaction assay for quantitative detection of Enterocytozoon bieneusi DNA in stool specimens from immunocompromised patients with intestinal microsporidiosis.
Menotti J; Cassinat B; Porcher R; Sarfati C; Derouin F; Molina JM
J Infect Dis; 2003 May; 187(9):1469-74. PubMed ID: 12717629
[TBL] [Abstract][Full Text] [Related]
11. Microsporidiosis: an emerging and opportunistic infection in humans and animals.
Didier ES
Acta Trop; 2005 Apr; 94(1):61-76. PubMed ID: 15777637
[TBL] [Abstract][Full Text] [Related]
12. Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient.
Kicia M; Sędzimirska M; Sak B; Kváč M; Wesołowska M; Hendrich AB; Kopacz Ż
Int J Infect Dis; 2018 Dec; 77():26-28. PubMed ID: 30063985
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study.
Maillard A; Scemla A; Laffy B; Mahloul N; Molina JM
J Antimicrob Chemother; 2021 Jan; 76(2):487-494. PubMed ID: 33128055
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model.
Feng X; Reddy VK; Mayanja-Kizza H; Weiss LM; Marton LJ; Tzipori S
Antimicrob Agents Chemother; 2009 Jun; 53(6):2417-23. PubMed ID: 19289524
[TBL] [Abstract][Full Text] [Related]
15. Fumagillin for intestinal microsporidiosis.
Carr A; Cooper DA
N Engl J Med; 2002 Oct; 347(17):1381; author reply 1381. PubMed ID: 12397205
[No Abstract] [Full Text] [Related]
16. Therapeutic targets for the treatment of microsporidiosis in humans.
Han B; Weiss LM
Expert Opin Ther Targets; 2018 Nov; 22(11):903-915. PubMed ID: 30336698
[TBL] [Abstract][Full Text] [Related]
17. Unusual pulmonary Enterocytozoon bieneusi microsporidiosis in an AIDS patient: case report and review.
Sodqi M; Brazille P; Gonzalez-Canali G; Cornet M; Piketty C; Weiss L
Scand J Infect Dis; 2004; 36(3):230-1. PubMed ID: 15119373
[TBL] [Abstract][Full Text] [Related]
18. Microsporidiosis: epidemiology, clinical data and therapy.
Anane S; Attouchi H
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):450-64. PubMed ID: 20702053
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS-SPORE registry.
Dumond C; Aulagnon F; Etienne I; Heng AE; Bougnoux ME; Favennec L; Kamar N; Iriart X; Pereira B; Büchler M; Desoubeaux G; Kaminski H; Lussac-Sorton F; Gargala G; Anglicheau D; Poirier P; Scemla A; Garrouste C;
Transpl Infect Dis; 2021 Oct; 23(5):e13708. PubMed ID: 34324771
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for human microsporidia infections.
Didier ES; Maddry JA; Brindley PJ; Stovall ME; Didier PJ
Expert Rev Anti Infect Ther; 2005 Jun; 3(3):419-34. PubMed ID: 15954858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
